A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies-Reference-Cited by-同舟云学术

A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies

Published:2015-07-07 Issue:12 Volume:62 Page:2120-2124
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Cacciavillano Walter¹,Sampor Claudia¹,Venier Cecilia²,Gabri Mariano R.³,de Dávila María T.G.¹,Galluzzo Maria L.¹,Guthmann Marcelo D.⁴,Fainboim Leonardo²,Alonso Daniel F.³,Chantada Guillermo L.¹

Affiliation:

1. Hospital de Pediatría SAMIC “Prof Dr Juan P Garrahan”; Buenos Aires Argentina

2. Institute of Immunology, Genetics and Metabolism (INIGEM), University of Buenos Aires; National Council for Scientific and Technological Research (CONICET); Buenos Aires Argentina

3. Laboratory of Molecular Oncology; National University of Quilmes; Buenos Aires Argentina

4. Elea Laboratories; Buenos Aires Argentina

Funder

Instituto Nacional del Cancer (Argentina)

ANPCyT (Argentina)

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25631/fullpdf

Reference30 articles.